The Bottleneck in DeepTech Investing Is No Longer Dealflow
Network access was long considered a competitive advantage in venture capital — that advantage has been commoditised.
Network access was long considered a competitive advantage in venture capital — that advantage has been commoditised.
Strong technology alone does not make a DeepTech company investable.
One of the most persistent misconceptions in HealthTech is assuming that strong science naturally leads to scalable growth.
One of the biggest structural mistakes in DeepTech investing is applying software-style scaling assumptions to ClimateTech.